Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

HLA-DRB1 Antikörper (AA 30-266)

HLA-DRB1 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN1869178
  • Target Alle HLA-DRB1 Antikörper anzeigen
    HLA-DRB1 (Major Histocompatibility Complex, Class II, DR beta 1 (HLA-DRB1))
    Bindungsspezifität
    • 14
    • 8
    • 6
    • 5
    • 4
    • 3
    • 1
    • 1
    • 1
    AA 30-266
    Reaktivität
    • 96
    • 31
    • 11
    • 11
    • 11
    • 11
    • 10
    • 8
    Human
    Wirt
    • 54
    • 43
    Kaninchen
    Klonalität
    • 53
    • 44
    Polyklonal
    Konjugat
    • 42
    • 9
    • 8
    • 6
    • 5
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser HLA-DRB1 Antikörper ist unkonjugiert
    Applikation
    • 62
    • 46
    • 39
    • 25
    • 18
    • 18
    • 14
    • 8
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Verwendungszweck
    Polyclonal Antibody to HLA Class II Histocompatibility Antigen, DRB1 Beta Chain (HLA-DRB1)
    Spezifität
    The antibody is a rabbit polyclonal antibody raised against HLA-DRB1. It has been selected for its ability to recognize HLA-DRB1 in immunohistochemical staining and western blotting.
    Kreuzreaktivität
    Schwein, Ratte
    Aufreinigung
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogen
    Recombinant HLA Class II Histocompatibility Antigen, DRB1 Beta Chain (HLA-DRB1) corresdonding to Gly30~Ser266 with N-terminal His Tag
    Isotyp
    IgG
    Top Product
    Discover our top product HLA-DRB1 Primärantikörper
  • Applikationshinweise

    Western blotting: 0.5-2 μg/mL

    Immunohistochemistry: 5-20 μg/mL

    Immunocytochemistry: 5-20 μg/mL

    Optimal working dilutions must be determined by end user.

    Kommentare

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    Lot specific
    Buffer
    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
    Handhabung
    Avoid repeated freeze-thaw cycles.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Haltbarkeit
    24 months
  • Target
    HLA-DRB1 (Major Histocompatibility Complex, Class II, DR beta 1 (HLA-DRB1))
    Andere Bezeichnung
    HLA Class II Histocompatibility Antigen, DRB1 Beta Chain (HLA-DRB1 Produkte)
    Synonyme
    MGC108235 antikoerper, DRB1 antikoerper, DRw10 antikoerper, HLA-DR1B antikoerper, HLA-DRB antikoerper, SS1 antikoerper, major histocompatibility complex, class II, DR beta 1 antikoerper, hla-drb1 antikoerper, HLA-DRB1 antikoerper
    Hintergrund
    HLA-DRB1, MHCDRb1, HLADRb1, Major Histocompatibility Complex Class II DR Beta 1, HLA Class II Histocompatibility Antigen,DRB1-9 Beta Chain, HLA class II histocompatibility antigen, DRB1-15 beta chain
    Pathways
    T-Zell Rezeptor Signalweg, Positive Regulation of Peptide Hormone Secretion, Production of Molecular Mediator of Immune Response, CXCR4-mediated Signaling Events, Cancer Immune Checkpoints
Sie sind hier:
Kundenservice